Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants
European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-017-2226-2
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2017
Authors
Publisher
Springer Science and Business Media LLC